David B. Roberts - Sep 4, 2025 Form 4 Insider Report for LEMAITRE VASCULAR INC (LMAT)

Role
President and Director, Director
Signature
/s/ Nathan Ulrich
Stock symbol
LMAT
Transactions as of
Sep 4, 2025
Transactions value $
$0
Form type
4
Date filed
9/8/2025, 06:12 PM
Previous filing
Aug 13, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Roberts David B President and Director, Director C/O LEMAITRE VASCULAR, INC., 63 SECOND AVENUE, BURLINGTON /s/ Nathan Ulrich 2025-09-08 0001365731

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LMAT Dividend Equivalent Rights Award $0 +0.721 +4.38% $0.00 17.2 Sep 4, 2025 Common Stock 0.721 Direct F1
transaction LMAT Dividend Equivalent Rights Award $0 +1.37 +5.71% $0.00 25.4 Sep 4, 2025 Common Stock 1.37 Direct F2
transaction LMAT Dividend Equivalent Rights Award $0 +2.79 +8.72% $0.00 34.8 Sep 4, 2025 Common Stock 2.79 Direct F3
transaction LMAT Dividend Equivalent Rights Award $0 +2.79 +8.91% $0.00 34.1 Sep 4, 2025 Common Stock 2.79 Direct F4
transaction LMAT Dividend Equivalent Rights Award $0 +3.58 +16.05% $0.00 25.9 Sep 4, 2025 Common Stock 3.58 Direct F5
transaction LMAT Dividend Equivalent Rights Award $0 +4.29 +18.67% $0.00 27.3 Sep 4, 2025 Common Stock 4.29 Direct F6
transaction LMAT Dividend Equivalent Rights Award $0 +2.76 +42.65% $0.00 9.25 Sep 4, 2025 Common Stock 2.76 Direct F7
transaction LMAT Dividend Equivalent Rights Award $0 +0.267 +42.37% $0.00 0.894 Sep 4, 2025 Common Stock 0.267 Direct F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These dividend equivalent rights accrued on a restricted stock unit award granted on 12/2/2020 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F2 These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F3 These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F4 These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F5 These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F6 These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F7 These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F8 These dividend equivalent rights accrued on a restricted stock unit award granted on 2/18/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.